SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
PEN

Penumbra Inc (New York Stock Exchange:PEN)

US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
$319.12-$0.89 (-0.28%)
 
Market cap
$12.6B
Insider Score
Health Score
Analyst consensus
Listed since
Sep 18, 2015
Market Cap$12.58B+7.0%
Revenue (ttm)$1.56B+17.0%
Net Income$157.02M-4.3%
EPS$3.97-5.0%
Shares Out39.41M
PE Ratio79.98
Forward PE53.77
Dividendn/a
Ex-Dividend Daten/a
Volume205,407
Open$319.91
Previous Close$320.01
Day's Range$319.02 - $320.32
52-Week Range$284.95 - $362.41
Beta0.69
AnalystsHold
Price Target$320.00(+0.28%)
Earnings DateFeb 24, 2027

About PEN

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

Address
One Penumbra Place, Alameda, CA, 94502, US
Market Cap
12.58 billion
Employees
4,700
Industrial Classification
Medical - Devices

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$865.30K
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Strong
From PEN’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-0.28%
5 Days
-0.89%
1 Month
-1.80%
6 Months
-2.91%
1 Year
+7.05%

$PEN stock is featured in our Congress Trading, and Insider Trades datasets.

→ All Stock Lists

Congress Trading

Recent trades of PEN by members of U.S. Congress

Lisa C. McClainHouse / RSale$1.00K – $15.00KJul 10, 2025

Recently reported changes in PEN holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by PEN's directors and management

Net Shares Purchased by Insiders−3k−2k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

PEN Estimated quarterly lobbying spending

Source: U.S. Senate LDA

PEN Revenue by Segment or Geography

$820.29MTotal
Revenue from contract with customer$410.14M50.00%
Thrombectomy$279.16M34.03%
Embolization and Access$130.99M15.97%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New PEN patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to PEN from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in PEN

IJHiShares Core S&P Mid-Cap ETF$454.22M
VTIVanguard Morningstar Total Stock Market ETF$299.06M
VBVanguard Morningstar Small-Cap ETF$267.59M
VBKVanguard Morningstar Small-Cap Growth ETF$149.76M
VXFVanguard Extended Market ETF$142.17M
MDYState Street SPDR S&P MIDCAP 400 ETF Trust$94.37M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from PEN’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
0
Analyst Ratings
40% of score
55
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
0
Sells
2
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

BTALAGF U.S. Market Neutral Anti-Beta Fund3.97%
EVNTAltShares Event-Driven ETF2.56%
ARBAltShares Merger Arbitrage ETF2.50%
MDEVFirst Trust Indxx Medical Devices ETF1.88%
HTECROBO Global Healthcare Technology and Innovation ETF1.75%
IHIiShares U.S. Medical Devices ETF1.57%
AUSFGlobal X - Adaptive U.S. Factor ETF1.55%
XHEState Street SPDR S&P Health Care Equipment ETF1.52%
MNTLTema Neuroscience And Mental Health ETF1.46%
ZUH.TOBMO Equal Weight US Health Care Hedged to CAD Index ETF1.06%
RFGInvesco S&P MidCap 400 Pure Growth ETF1.05%
ZHU.TOBMO Equal Weight US Health Care Index ETF1.03%

Weight is the stock’s share of each fund’s holdings.